Commonwealth Equity Services’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Sell |
33,686
-1,490
| -4% | -$16.8K | ﹤0.01% | 3389 |
|
|
2025
Q1 | $355K | Buy |
35,176
+15,588
| +80% | +$157K | ﹤0.01% | 3331 |
|
|
2024
Q4 | $232K | Buy |
19,588
+3,813
| +24% | +$45.2K | ﹤0.01% | 3635 |
|
|
2024
Q3 | $182K | Buy |
15,775
+1,071
| +7% | +$12.4K | ﹤0.01% | 3741 |
|
|
2024
Q2 | $155K | Sell |
14,704
-4,224
| -22% | -$44.5K | ﹤0.01% | 3716 |
|
|
2024
Q1 | $200K | Buy |
18,928
+1,599
| +9% | +$16.9K | ﹤0.01% | 3629 |
|
|
2023
Q4 | $195K | Buy |
+17,329
| New | +$195K | ﹤0.01% | 3520 |
|